Jeffrey Ubben recent buys & sells (2014 Q4)
ValueAct Holdings
ValueAct Holdings Portfolio Changes
Purchase & sale details
- Portfolio value:
- $15.96B (+$1B)
- Previous value:
- $14.92B
- # of changes:
- 12
- New positions:
- 2
- Reported for:
- 31 Dec 2014 (Q4)
- Latest filing date:
- 17 Feb 2015
ValueAct Holdings has disclosed a total of 12 changes to the portfolio in the (2014 Q4) SEC report(s): increased the number of shares of 5, bought 2 totally new, decreased the number of shares of 4 and completely sold out 1 position(s).
What stocks did Jeffrey Ubben buy in 2014 Q4?
During 2014 Q4 Jeffrey Ubben has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (MSFT) Microsoft Corp (reduced shares 0.00%), (VRX) Valeant Pharmaceuticals International Inc (added shares +2.43%), (FOX) Fox Corp, CL-B (added shares +20.24%), (BHI) Baker Hughes Inc (new buy) and (HAL) Halliburton Company (new buy).
In the 2014 Q4 report(s) the following changes have been made to the top investments: (MSFT) Microsoft Corp (reduced shares 0.00%), (VRX) Valeant Pharmaceuticals International Inc (added shares +2.43%), (MSI) Motorola Solutions Inc (reduced shares -39.16%), (ADBE) Adobe Inc (reduced shares -32.91%) and (FOX) Fox Corp, CL-B (added shares +20.24%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".